COMP <GO>
USNA vs NAGE // ALTMAN Z-SCORE & DEBT/EQUITY
USANA Health Sciences Inc. (NYSE) VS. Niagen Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: USNA 4
— NAGE 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NAGE
LAST: $14.34 (-1.91%) • MKT CAP: $265.0M
balance-sheet
3.56
LAST: $2.50 (-1.57%) • MKT CAP: $197.8M
balance-sheet
4.40
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USNA VS. NAGE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USNA | NAGE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.30% | 64.30% | +14.00 | USNA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.90% | 16.80% | -8.90 | NAGE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.7x | 12.2x | -9.50 | USNA | /valuation <GO> |
| Free Cash Flow Yield | 3.22% | 6.83% | -3.61 | NAGE | /fcf-yield <GO> |
| Operating Margin | 4.00% | 12.60% | -8.60 | NAGE | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 13.40% | -12.20 | NAGE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 29.90% | -21.60 | NAGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.56 | 4.40 | -0.84 | NAGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 30.2 | +15.05 | USNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 9.6x | +13.30 | NAGE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $265.0M | $197.8M | $67.1M | USNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USNA REV | NAGE REV | USNA GROSS % | NAGE GROSS % | USNA FCF | NAGE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $925.3M | $129.4M | 78.3% | 64.3% | $8.5M | $13.5M |
| FY 2024 | $854.5M | $99.6M | 81.1% | 61.8% | $50.9M | $12.1M |
| FY 2023 | $921.0M | $83.6M | — | — | $70.6M | $7.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USNA // BETA —
NAGE // BETA —